Onset of eosinophilic esophagitis during a clinical trial program of oral immunotherapy for peanut allergy

J Allergy Clin Immunol Pract. 2021 Dec;9(12):4496-4501. doi: 10.1016/j.jaip.2021.07.048. Epub 2021 Aug 11.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Allergens
  • Arachis
  • Desensitization, Immunologic
  • Enteritis*
  • Eosinophilic Esophagitis* / therapy
  • Gastritis*
  • Humans
  • Peanut Hypersensitivity* / therapy

Substances

  • Allergens

Associated data

  • ClinicalTrials.gov/NCT01987817
  • ClinicalTrials.gov/NCT02198664
  • ClinicalTrials.gov/NCT02635776
  • ClinicalTrials.gov/NCT02993107
  • ClinicalTrials.gov/NCT03126227
  • ClinicalTrials.gov/NCT03292484
  • ClinicalTrials.gov/NCT03201003
  • ClinicalTrials.gov/NCT03337542